Katherine Miszkiel

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +16

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

Leonora Fisniku, P A Brex, Daniel R. Altmann et al. · Brain · 2008 · 894 citations · Full text

Medicine, Neurology, Neuroscience +15

Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy

Tarek A Yousry, Eugene O. Major, Caroline F. Ryschkewitsch et al. · New England Journal of Medicine · 2006 · 792 citations · Full text

Medicine, Infectious Diseases, Neurology +14

Gray matter atrophy is related to long‐term disability in multiple sclerosis

Leonora Fisniku, Declan Chard, Jonathan S. Jackson et al. · Annals of Neurology · 2008 · 505 citations

Medicine, Neurology, Neuroscience +16

MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study

Josephine Swanton, Àlex Rovira, Mar Tintoré et al. · The Lancet Neurology · 2007 · 329 citations

Medicine, Neurology, Radiology +11